As Investments Opportunities Pile Up for Its Biotech Portfolio Model Strategy, Healthtech Solutions Inc. (HLTT) Taps New CEO After First Acquisition
Dr. Edward “Ned” Swanson has joined Healthtech as CEO, bringing decades of scientific, clinical, industry and capital markets experience, including founding NASDAQ-listed company, to HLTT Healthtech in recent months has committed to a portfolio strategy, where it will bring diverse group of healthtech companies forward Company acquired precision oncology company Varian Biopharmaceuticals Inc. (“VarianBio”) in May, adding it to their family of companies that already included MediScan and RevHeart The biotech portfolio model is hot, with over $5.5 billion in capital raised in the last six years Historically, biotech companies built value nearly exclusively with a straightforward approach centered on…